Idiopathic Inflammatory Myositis
📧 Sign up to get email alerts when something new happens for Idiopathic Inflammatory Myositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
A Phase 2/3 clinical trial update reports on safety and efficacy of ULSC for reducing disease severity and enabling steroid tapering in Derm…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease [Phase 1]
Phase 1 study update for FT819 in B-cell–mediated autoimmune diseases; recruitment is ongoing for ANCA-associated vasculitis, idiopathic inf…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing rituximab to cyclophosphamide in connective tissue disease–associated interstitial lung disease has comple…